April, 2020 | The Health
| Issue |
At the moment,
Malaysia’s
contribution
to the Islamic
global economy
is only
0.47 per cent.”
— Mahmud Abbas
Launching the symposium is Dato' Mahmud. Looking on is Prof Dato' Dr Imran.
U
NIVERSITI Kebangsaan
Malaysia (UKM) through
its Halal Pharmaceutical
Business Initiatives
(HPBI-UKM) in collaboration
with Duopharma Biotech
Berhad organised the ‘Halal
Pharmaceutical Symposium
2020’ on Feb 25, 2020. The symposium
was launched by Chairman of Halal
Development Corporation (HDC) Dato’
Mahmud Abbas, Chairman of Halal
Development Corporation (HDC).
The symposium, with its theme
“Fostering a Vibrant Halal Pharmaceutical
Research and Academic Community” was
to generate more research community and
academicians on halal pharmaceuticals.
This is in line with their agreement
on strategic collaboration for research
partnership signed last year.
Duopharma is the first pharmaceutical
company in Malaysia to obtain Halal
Certification for Prescriptive Medicines
based on the world’s first halal
pharmaceutical standard, the MS2424.
HPBI-UKM embodies UKM Graduate
School of Business (GSB), the Faculty of
Pharmacy (FFar), Faculty of Islamic Studies
(FPI), UKM-UNIOEQ and Faculty of Science
and Technology (FST).
These forms of collaboration between
universities and industries is line with
a call made by the Ministry of Education
to achieve a greater educational and
available at selected private hospitals.
Dzulkifly also mentioned that
the media plays a big role in
disseminating information on the
importance of screening and knowing
the signs and symptoms, including
prompt and correct choice of proven
therapy.
"No matter how big or small you
are, you have the power to reduce the
impact of cancer for yourself, for the
people you love and for the world," he
said. — The Health
Pumping up more halal
pharmaceutical research
New innovations are needed for better optimization of the halal
value chain through collaborative events
technological development, skill
development as well as management skills.
According to the Deputy Vice-
Chancellor of Industry and Community
Partnerships of Universiti Kebangsaan
Malaysia, Prof Dato’ Dr Imran Ho Abdullah,
there were four research projects
conducted, led by lecturers from GSB, FFar,
FPI and FST. The research projects are fully
funded through research grants provided
by Duopharma totaling RM130,000.
“I believe the implications of these
four research projects is important to
the government especially the Ministry
of Health (MOH) Islamic enforcement
agencies, hospitals, clinics, pharmacies,
and also enhance the guidelines on halal
medicines,” he added.
The image of the halal pharmaceutical
Dato Mahmud (middle)
and Dr Imran.
industry needs to be potrayed with care
because the management of the halal
value chain is increasingly critical.
New innovations are needed for better
optimization of halal value chains through
collaborative events with various parties.
Mahmud said, “At the moment,
Malaysia’s contribution to the islamic
global economy is only 0.47 per cent.
Our contribution is a drop in the ocean.
The growth of the halal pharmaceutical
industry worldwide is huge. Its potential
value of development is wide. When we
look through the Islamic Global Economy
Report 2018/2019, the expenditure on
pharmaceutical products by Muslims
in 2018 was up to US$92 billion. By 2024,
the numbers are estimated to increase to
US$134 billion.”
The potential of the halal
pharmaceutical is huge, but there is more
work to be done by Malaysia. “Through
this symposium, we will ensure there is
a complete dissemination of information
on the strategic development of the halal
pharmaceutical industry. Major issues in
halal value chain will also be put forth in
order to have continuous improvements,”
he said.
UKM and Duopharma are hoping the
Halal Pharmaceutical Symposium 2020
will be a great contribution to the halal
pharmaceutical industry in the country
and be a small step towards bigger
collaborations. — The Health
25